Off-label Use of Recombinant Activated Factor VII for Cardiac Surgical Bleeding

被引：5

作者：

Flynn, Brigid C. ^{[1
,4
]}

Steiner, Marie E. ^{[2
]}

Mazzeffi, Michael ^{[3
]}

机构：

[1] Univ Kansas, Dept Anesthesiol, Med Ctr, Kansas City, KS USA

[2] Univ Minnesota, Div Hematol Oncol & Crit Care, Minneapolis, MN USA

[3] Univ Virginia, Dept Anesthesiol, Sch Med, Charlottesville, VA USA

[4] Univ Kansas, Dept Anesthesiol, Med Ctr, Kansas City, KS 66160 USA

来源：

ANESTHESIOLOGY | 2023年 / 139卷 / 02期

关键词：

BLOOD-CELL TRANSFUSIONS; ACUTE AORTIC DISSECTION; INTRAOPERATIVE USE; DOUBLE-BLIND; SURGERY; SAFETY; NOVOSEVEN(R); MANAGEMENT; EFFICACY; RFVIIA;

D O I：

10.1097/ALN.0000000000004569

中图分类号：

R614 [麻醉学];

学科分类号：

100217 ;

摘要：

This review discusses the history and present-day off-label use of recombinant activated factor VII for cardiac surgical bleeding.

引用

页码：197 / 210

页数：14

共 68 条

[51]

NovoSevenRT, BL 103665

[52]

Payani Narges, 2015, Anesth Pain Med, V5, pe22846, DOI 10.5812/aapm.22846

[53] Activated recombinant factor VII for control of diffuse bleeding after implantation of ventricular assist device [J].

Potapov, EV ;

Pasic, M ;

Bauer, M ;

Hetzer, R .

ANNALS OF THORACIC SURGERY, 2002, 74 (06) :2182-2183

[54] Society of Cardiovascular Anesthesiologists Clinical Practice Improvement Advisory for Management of Perioperative Bleeding and Hemostasis in Cardiac Surgery Patients [J].

Raphael, Jacob ;

Mazer, C. David ;

Subramani, Sudhakar ;

Schroeder, Andrew ;

Abdalla, Mohamed ;

Ferreira, Renata ;

Roman, Philip E. ;

Patel, Nichlesh ;

Welsby, Ian ;

Greilich, Philip E. ;

Harvey, Reed ;

Ranucci, Marco ;

Heller, Lori B. ;

Boer, Christa ;

Wilkey, Andrew ;

Hill, Steven E. ;

Nuttall, Gregory A. ;

Palvadi, Raja R. ;

Patel, Prakash A. ;

Wilkey, Barbara ;

Gaitan, Brantley ;

Hill, Shanna S. ;

Kwak, Jenny ;

Klick, John ;

Bollen, Bruce A. ;

Shore-Lesserson, Linda ;

Abernathy, James ;

Schwann, Nanette ;

Lau, W. Travis .

ANESTHESIA AND ANALGESIA, 2019, 129 (05) :1209-1221

[55] Recombinant factor VIIa for uncontrollable bleeding in patients with extracorporeal membrane oxygenation: report on 15 cases and literature review [J].

Repesse, Xavier ;

Au, Siu Ming ;

Brechot, Nicolas ;

Trouillet, Jean-Louis ;

Leprince, Pascal ;

Chastre, Jean ;

Combes, Alain ;

Luyt, Charles-Edouard .

CRITICAL CARE, 2013, 17 (02)

[56] Small-dose recombinant activated factor VII (NovoSeven®) in cardiac surgery [J].

Romagnoli, S ;

Bevilacqua, S ;

Gelsomino, S ;

Pradella, S ;

Ghilli, L ;

Rostagno, C ;

Gensini, GF ;

Sorbara, C .

ANESTHESIA AND ANALGESIA, 2006, 102 (05) :1320-1326

[57] Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia [J].

Simpson, Ewurabena ;

Lin, Yulia ;

Stanworth, Simon ;

Birchall, Janet ;

Doree, Carolyn ;

Hyde, Chris .

COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (03)

[58] Activated recombinant factor VII in cardiac surgery [J].

Steiner, Marie E. ;

Key, Nigel S. ;

Levy, Jerrold H. .

CURRENT OPINION IN ANESTHESIOLOGY, 2005, 18 (01) :89-92

[59] Impact of Early, Low-Dose Factor VIIa on Subsequent Transfusions and Length of Stay in Cardiac Surgery [J].

Sutherland, Lauren ;

Houchin, Abigail ;

Wang, Tian ;

Wang, Shuang ;

Moitra, Vivek ;

Sharma, Akshit ;

Zorn, Trip ;

Flynn, Brigid C. .

JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2022, 36 (01) :147-154

[60] Treatment of excessive bleeding in Jehovah's Witness patients after cardiac surgery with recombinant factor VIIa (NovoSeven®) [J].

Tanaka, KA ;

Waly, AA ;

Cooper, WA ;

Levy, JH .

ANESTHESIOLOGY, 2003, 98 (06) :1513-1515

← 1 2 3 4 5 6 7 →